ClinicalTrials.Veeva

Menu

Discomfort in Upper Airways Due to intubation-a Randomized Controlled Trial

O

Ostfold University College

Status

Completed

Conditions

Postoperative Complications
Intubation Complication
Intubation; Difficult or Failed

Treatments

Drug: Lidocaine topical

Study type

Interventional

Funder types

Other

Identifiers

NCT05614609
Sykehuset Østfold

Details and patient eligibility

About

Few studies have compared different methods for optimalizing intubation conditions in general anesthesia. This randomized controlled trial will compare two different methods for intubation in general anesthesia in gastro- or gynecological procedures.

Full description

In general anesthesia, it is neccessary to secure the airways with an endotracheal tube. There is no international consensus on how intubation is most efficiently conducted. A cochrane review compared using muscular relaxing medication versus not using blocks for intubation. Primary outcomes were intubation conditions and discomfort in upper airways. The authors concluded that research is limited, and that further research is needed. No studies have compared local anesthetic spray on the glottis and muscular relaxing medication in intubation, focusing on discomfort in upper airways. The null-hypothesis of this study is that there is no difference in upper airway discomfort when using local anesthetic spray or muscular relaxing medication. The study will have a randomized controlled design, randomizing patients undergoing gastro- or gynecological procedures in general anesthesia to receiving either rocuronium (muscle relaxing medication) intravenous, or lidocain spray on the glottis before intubation. The primary outcome is postoperativ hoarseness one hour after intubation.

Enrollment

120 patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ASA (American Association of Anesthesiologists Classification system for physical status) I-III
  • Understand and can express themselves in Norwegian
  • Able to give informed consent to participate

Exclusion criteria

  • Cave lidocain and/or muscle relaxing medication
  • BMI above 40
  • Anticipated difficult intubation
  • Need for ventricular tube
  • Pathology or malformations in upper airways

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

120 participants in 2 patient groups

Lidocaine spray on the glottis
Active Comparator group
Description:
Lidocaine 20 mgl/ml- 4,4 ml will be sprayed on the glottis. Ventilation for 90 sek, intubation
Treatment:
Drug: Lidocaine topical
Muscle relaxing medication
Active Comparator group
Description:
Rocuronium 0,6 mg/kg administered intravenous. Ventilation for 2.5 minutes (150seconds), intubation
Treatment:
Drug: Lidocaine topical

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems